Archon Biosciences Announces $20 Million Seed Financing
October 31, 2024
October 31, 2024
PALO ALTO, California, Oct. 31 -- Cooley, a law firm, issued the following news release:
Seattle - October 30, 2024 - Cooley advised Archon Biosciences, a biotechnology company pioneering computationally designed antibody cages (AbCs) to unlock powerful therapeutic targets beyond the reach of existing modalities, on its $20 million seed financing.
Madrona Ventures led the financing, with participation from DUMAC, Sahsen Ventures, WRF Capital, Pack Ventures, Alexandria V . . .
Seattle - October 30, 2024 - Cooley advised Archon Biosciences, a biotechnology company pioneering computationally designed antibody cages (AbCs) to unlock powerful therapeutic targets beyond the reach of existing modalities, on its $20 million seed financing.
Madrona Ventures led the financing, with participation from DUMAC, Sahsen Ventures, WRF Capital, Pack Ventures, Alexandria V . . .